Cargando…

The Challenging Road of Moving from Association to Causation for Microbiome Research in Idiopathic Pulmonary Fibrosis

Detalles Bibliográficos
Autores principales:	Segal, Leopoldo N., Molyneaux, Philip L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515869/ https://www.ncbi.nlm.nih.gov/pubmed/30807204 http://dx.doi.org/10.1164/rccm.201902-0318ED

Ejemplares similares

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2019)

The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2021)

The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2019)

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
por: Molyneaux, Philip L., et al.
Publicado: (2017)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management
por: Baldi, Bruno Guedes
Publicado: (2017)

The Lung Microbiome in Health, Hypersensitivity Pneumonitis, and Idiopathic Pulmonary Fibrosis: A Heavy Bacterial Burden to Bear
por: O’Dwyer, David N., et al.
Publicado: (2021)

Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ
por: Wang, Jing, et al.
Publicado: (2017)

The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research
por: Dempsey, Timothy M., et al.
Publicado: (2023)

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
por: Woodcock, Hannah V, et al.
Publicado: (2013)

Lung transplant in familial pulmonary fibrosis: the road ahead
por: Esposito, Anthony Joseph, et al.
Publicado: (2020)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?
por: Singh, Shivani, et al.
Publicado: (2021)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019)

Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis
por: Kreuter, Michael, et al.
Publicado: (2021)

Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles
por: Asghar, Sabha, et al.
Publicado: (2023)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

Lung Tissue Microbiome Is Associated With Clinical Outcomes of Idiopathic Pulmonary Fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2021)

Six-minute walk test in patients with idiopathic pulmonary fibrosis
por: Baddini-Martinez, José Antônio
Publicado: (2018)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
por: Poletti, Venerino
Publicado: (2014)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Assessing the Burden and Prognostic Value of Cough in Idiopathic Pulmonary Fibrosis
por: Johnston, Janet, et al.
Publicado: (2023)

Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy
por: Cascante Rodrigo, Jose Antonio, et al.
Publicado: (2022)

Genetic Association Study Advances Idiopathic Pulmonary Fibrosis Pathophysiology and Health Equity
por: Hobbs, Brian D.
Publicado: (2022)

Idiopathic Scoliosis: Novel Challenges for Researchers and Clinicians
por: Zaina, Fabio, et al.
Publicado: (2023)

Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?
por: Polverino, Francesca
Publicado: (2023)

Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region
por: Di Bidino, Rossella, et al.
Publicado: (2022)

Crossing Kingdoms: Host–Microbial Endotyping and the Quest to Understand Treatable Traits in Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_37bcbqa2c2j5sep1ictlcojav6